A detailed history of Lazard Asset Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 17,010 shares of VCEL stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,010
Previous 3,362 405.95%
Holding current value
$1 Million
Previous $154,000 366.23%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.25 - $53.56 $576,628 - $730,986
13,648 Added 405.95%
17,010 $718,000
Q2 2024

Aug 14, 2024

BUY
$41.71 - $52.9 $32,450 - $41,156
778 Added 30.11%
3,362 $154,000
Q1 2024

May 14, 2024

BUY
$32.52 - $52.33 $53,885 - $86,710
1,657 Added 178.75%
2,584 $134,000
Q4 2023

Feb 14, 2024

SELL
$30.85 - $37.09 $103,717 - $124,696
-3,362 Reduced 78.39%
927 $33,000
Q3 2023

Nov 14, 2023

BUY
$31.69 - $39.25 $26,112 - $32,342
824 Added 23.78%
4,289 $143,000
Q2 2022

Aug 09, 2022

BUY
$22.88 - $39.45 $40,840 - $70,418
1,785 Added 106.25%
3,465 $87,000
Q1 2022

May 13, 2022

SELL
$31.69 - $43.29 $5,989 - $8,181
-189 Reduced 10.11%
1,680 $64,000
Q4 2021

Feb 09, 2022

BUY
$35.2 - $52.6 $7,603 - $11,361
216 Added 13.07%
1,869 $73,000
Q3 2021

Nov 15, 2021

BUY
$46.35 - $59.75 $76,616 - $98,766
1,653 New
1,653 $80,000
Q2 2021

Aug 12, 2021

SELL
$47.2 - $67.81 $163,312 - $234,622
-3,460 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$18.53 - $31.5 $22,402 - $38,083
1,209 Added 53.71%
3,460 $106,000
Q3 2020

Nov 13, 2020

SELL
$14.68 - $19.12 $14,694 - $19,139
-1,001 Reduced 30.78%
2,251 $41,000
Q2 2020

Aug 13, 2020

SELL
$8.5 - $15.82 $21,709 - $40,404
-2,554 Reduced 43.99%
3,252 $44,000
Q1 2020

May 14, 2020

BUY
$7.25 - $19.22 $26,781 - $70,998
3,694 Added 174.91%
5,806 $53,000
Q4 2019

Feb 13, 2020

BUY
$13.77 - $19.2 $17,308 - $24,134
1,257 Added 147.02%
2,112 $36,000
Q3 2019

Nov 14, 2019

BUY
$14.93 - $19.83 $12,765 - $16,954
855 New
855 $12,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.78B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.